Node metastases are CD10+, whereas the CD26+ cancer cells are CD10-, so it is possible that LNCaP is a representative of the CD10+ cancer cell type found in ~30% of prostate tumors and nearly all positive nodes [8]. This evidence concerns the gene DPP4 and cancer.